Identification of a novel cytokine, ML-1, and its expression in subjects with asthma

Citation
M. Kawaguchi et al., Identification of a novel cytokine, ML-1, and its expression in subjects with asthma, J IMMUNOL, 167(8), 2001, pp. 4430-4435
Citations number
26
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGY
ISSN journal
00221767 → ACNP
Volume
167
Issue
8
Year of publication
2001
Pages
4430 - 4435
Database
ISI
SICI code
0022-1767(20011015)167:8<4430:IOANCM>2.0.ZU;2-3
Abstract
A novel gene, designated ML-1, was identified front a human genomic DNA clo ne and human T cell cDNA sequences. The second exon of ML-1 gene shares sig nificant sequence identity with the gene encoding IL-17 (IL-17). ML-1 gene expression was upregulated in activated PBMCs, CD4(+) T cells, allergen-spe cific Th0, Th1, and Th2 clones, activated basophils, and mast cells. Increa sed expression of the ML-1 gene, but not IL-17, was seen following allergen challenge in four asthmatic subjects, suggesting its role in allergic infl ammatory responses. ML-1 from transiently transfected COS-7 cells was able to induce gene expression and protein production for IL-6 and IL-8 (at 10 n g/ml of ML-1: for IL-6, 599.6 +/- 19.1 pg/ml; for IL-8, 1724.2 +/- 132.9 pg /ml; and at 100 ng/ml of ML-1: for IL-6, 1005.3 +/- 55.6 pg/ml; for IL-8, 4 371.4 +/- 280.5 pg/ml; p < 0.05 for both doses vs baseline) in primary bron chial epithelial (PBE) cells. Furthermore, increased expression of ICAM-1 w as found in ML-1-stimulated PBE cells (mean fluorescence intensity (MFI) = 31.42 +/- 4.39 vs baseline, MFI = 12.26 +/- 1.77, p < 0.05), a functional f eature distinct from IL-17 (MFI = 11.07 +/- 1.22). This effect was not inhi bited by a saturating amount of IL-17. These findings demonstrate that ML-1 is a novel cytokine with a distinct function, and suggest a different rece ptor for ML-1 on PBE cells.